Want to join the conversation?
For 3Q16, $NDSN expects sales to rise 1-5% vs. 3Q15. which includes organic volume down 1% to up 3%, 3% growth from first year effect of acquisitions & negative currency effect of 1% based on current exchange rate environment. At the midpoint of this, operating margin is expected to be approx. 24% & GAAP diluted EPS is expected to be $1.25-1.37.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?